We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOHU
1676
Sohu.com
SOHU
$376M
| $510K | ﹤0.01% |
30,751
| – | – |
|
1677
TETRA Technologies
TTI
$1.28B
| $510K | ﹤0.01% |
125,668
-73,533
| -37% | -$324K |
|
1678
FB Financial Corp
FBK
$3.04B
| $509K | ﹤0.01% |
12,987
-4,069
| -24% | -$164K |
|
|
AQUA
1679
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $509K | ﹤0.01% |
15,662
-22,928
| -59% | -$873K |
|
1680
Allegiant Air
ALGT
$2.41B
| $505K | ﹤0.01% |
4,469
-116
| -3% | -$16.7K |
|
1681
Ashland
ASH
$3.45B
| $504K | ﹤0.01% |
+4,971
| New | +$509K |
|
1682
Fox Factory Holding Corp
FOXF
$884M
| $502K | ﹤0.01% |
6,379
-18,620
| -74% | -$1.57M |
|
1683
Edgewell Personal Care
EPC
$1.29B
| $501K | ﹤0.01% |
14,759
+2,105
| +17% | +$75.7K |
|
1684
Worthington Enterprises
WOR
$2.79B
| $500K | ﹤0.01% |
18,749
-4,577
| -20% | -$133K |
|
1685
Kearny Financial
KRNY
$595M
| $499K | ﹤0.01% |
44,906
-77,350
| -63% | -$926K |
|
1686
Deluxe
DLX
$1.12B
| $498K | ﹤0.01% |
+22,996
| New | +$585K |
|
|
CVGW
1687
DELISTED
Calavo Growers
CVGW
| $496K | ﹤0.01% |
+11,897
| New | +$431K |
|
1688
Aviat Networks
AVNW
$270M
| $494K | ﹤0.01% |
19,718
-725
| -4% | -$21K |
|
1689
Bright Horizons
BFAM
$3.81B
| $490K | ﹤0.01% |
+5,797
| New | +$576K |
|
1690
Enphase Energy
ENPH
$5.41B
| $488K | ﹤0.01% |
2,636
-7,642
| -74% | -$1.38M |
|
1691
Suzano
SUZ
$10B
| $487K | ﹤0.01% |
51,342
+4,074
| +9% | +$42.8K |
|
1692
Ethan Allen Interiors
ETD
$598M
| $486K | ﹤0.01% |
24,026
+2,766
| +13% | +$65.4K |
|
1693
Moelis & Co
MC
$4.72B
| $486K | ﹤0.01% |
12,344
-47,013
| -79% | -$2.05M |
|
1694
WD-40
WDFC
$3.15B
| $482K | ﹤0.01% |
2,393
-241
| -9% | -$45K |
|
1695
Haemonetics
HAE
$3.94B
| $481K | ﹤0.01% |
7,434
-18,279
| -71% | -$1.08M |
|
1696
PTC Therapeutics
PTCT
$6.23B
| $481K | ﹤0.01% |
12,015
-23,960
| -67% | -$840K |
|
1697
Tyler Technologies
TYL
$13B
| $481K | ﹤0.01% |
1,460
-14,077
| -91% | -$5.16M |
|
|
DENN
1698
DELISTED
Denny's
DENN
| $480K | ﹤0.01% |
+55,285
| New | +$610K |
|
|
HAPN
1699
Happen Inc
HAPN
$2.24B
| $480K | ﹤0.01% |
41,079
-67,534
| -62% | -$951K |
|
|
SASR
1700
DELISTED
Sandy Spring Bancorp Inc
SASR
| $480K | ﹤0.01% |
12,280
-847
| -6% | -$34.6K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.